Dai, Jing
Sage Therapeutics (United States)
3 papers on CoChatORCID 0000-0002-9282-4052
Most cited papers
- Verified
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Althaus, A. L., Ackley, M. A., Belfort, G. M., Gee, S. M., Dai, J., Nguyen, D. P., Kazdoba, T. M., Modgil, A., Davies, P. A., Moss, S. J., et al. (2020) · Neuropharmacology
Neuroscience and Neuropharmacology ResearchTreatment of Major Depression
Cited by 135
- Verified
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor
Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., et al. (2017) · Journal of Medicinal Chemistry
Neuroscience and Neuropharmacology ResearchHeterocyclic Compound Synthesis and Bioactivity
Cited by 129
- Verified
Effect of intensive periodontal therapy on blood pressure and endothelial microparticles in patients with prehypertension and periodontitis: a randomized controlled trial
Zhou, Q., Xia, W., Ren, J., Yu, B., Tong, X., Chen, Y., Chen, S., Feng, L., Dai, J., Tao, J., et al. (2017) · Journal of Periodontology
Oral microbiology and periodontitis researchPeriodontal Regeneration and Treatments
Cited by 89
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free